These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 2516851

  • 41. [The study of intrapleural urokinase in the prevention of pleural thickening and loculated effusions by tuberculous pleurisy].
    Ding D, Deng Q, Zhang H.
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan; 24(1):32-4. PubMed ID: 11802936
    [Abstract] [Full Text] [Related]

  • 42. Pathogenesis of pleural plaques. Relationship of early cellular response and pathology.
    Sahn SA, Antony VB.
    Am Rev Respir Dis; 1984 Nov; 130(5):884-7. PubMed ID: 6497167
    [Abstract] [Full Text] [Related]

  • 43. Acid glycosaminoglycans in experimental pleural effusions.
    Satoh K, Arai H, Nagai H, Ito M, Sato H, Motomiya M, Konno K.
    Lung; 1987 Nov; 165(4):191-9. PubMed ID: 3114570
    [Abstract] [Full Text] [Related]

  • 44. Collagen-producing mesothelial cells in adriamycin-induced pleuritis in rat. Microautoradiographic study utilizing tritiated proline.
    Isoda K, Maeda T, Hamamoto Y.
    Acta Pathol Jpn; 1987 Aug; 37(8):1305-18. PubMed ID: 3673573
    [Abstract] [Full Text] [Related]

  • 45. [Therapeutic efficacy of a benzoxazinorifamycin, KRM-1648, combined with a immunopotentiator, LC9018, in Mycobacterium intracellulare infection induced in beige mice].
    Tomioka H, Sato K, Saito H, Hidaka T.
    Kekkaku; 1993 Dec; 68(12):751-4. PubMed ID: 8301917
    [Abstract] [Full Text] [Related]

  • 46. Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion.
    Li X, Wu G, Chen C, Zhao Y, Zhu S, Song X, Yin J, Lv T, Song Y.
    Front Immunol; 2021 Dec; 12():760683. PubMed ID: 34966384
    [Abstract] [Full Text] [Related]

  • 47. [Therapeutic means and methods in recurrent pleurisy].
    Ambăruş V, Cosovanu A, Ungureanu G, Hanganu E, Ionescu S, Grozdan R.
    Rev Med Chir Soc Med Nat Iasi; 1992 Dec; 96(3-4):157-62. PubMed ID: 1344849
    [Abstract] [Full Text] [Related]

  • 48. Role of MCP-1 in pleural effusion development in a carrageenan-induced murine model of pleurisy.
    Lansley SM, Cheah HM, Lee YC.
    Respirology; 2017 May; 22(4):758-763. PubMed ID: 27878909
    [Abstract] [Full Text] [Related]

  • 49. Plasma pharmacokinetics of adriamycin after intrapleural administration.
    Eksborg S, Lindfors A, Cedermark BJ.
    Med Oncol Tumor Pharmacother; 1984 May; 1(3):193-4. PubMed ID: 6544898
    [Abstract] [Full Text] [Related]

  • 50. [Antitumor activity of Lactobacillus casei YIT 9018 (LC 9018)--effect of administration route].
    Yokokura T, Kato I, Matsuzaki T, Mutai M, Satoh H.
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2427-33. PubMed ID: 6437346
    [Abstract] [Full Text] [Related]

  • 51. Prolonged retention of liposomes in the pleural cavity of normal mice and high tumor distribution in mice with malignant pleural effusion, after intrapleural injection.
    Marazioti A, Papadia K, Giannou A, Stathopoulos GT, Antimisiaris SG.
    Int J Nanomedicine; 2019 Nov; 14():3773-3784. PubMed ID: 31213801
    [Abstract] [Full Text] [Related]

  • 52. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Perez-Soler R, Shin DM, Siddik ZH, Murphy WK, Huber M, Lee SJ, Khokhar AR, Hong WK.
    Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
    [Abstract] [Full Text] [Related]

  • 53. Intrapleural interleukin-2-expressing oncolytic virotherapy enhances acute antitumor effects and T-cell receptor diversity in malignant pleural disease.
    Ekeke CN, Russell KL, Murthy P, Guo ZS, Soloff AC, Weber D, Pan W, Lotze MT, Dhupar R.
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):e313-e328. PubMed ID: 33485667
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Therapeutic and life-prolonging effect of intrapleural injection with a streptococcal preparation, OK-432, and IL2-cultured effusion lymphocytes to breast cancer patients with malignant pleural effusion.
    Hori T, Mise K, Kan N, Okino T, Satoh K, Yamasaki S, Teramura Y, Harada T, Ohgaki K, Kodama H.
    Biotherapy; 1992 Apr; 5(1):21-9. PubMed ID: 1389900
    [Abstract] [Full Text] [Related]

  • 58. Bacillus Calmette-Guérin-stimulated neutrophils release chemotaxins for monocytes in rabbit pleural spaces and in vitro.
    Antony VB, Sahn SA, Antony AC, Repine JE.
    J Clin Invest; 1985 Oct; 76(4):1514-21. PubMed ID: 3902892
    [Abstract] [Full Text] [Related]

  • 59. [Augmentation of antitumor activity of Lactobacillus casei YIT 8018 (LC 9018) in combination with various antitumor drugs].
    Matsuzaki T, Kato I, Yokokura T, Mutai M.
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):445-51. PubMed ID: 6200079
    [Abstract] [Full Text] [Related]

  • 60. Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial.
    Luh KT, Yang PC, Kuo SH, Chang DB, Yu CJ, Lee LN.
    Cancer; 1992 Feb 01; 69(3):674-9. PubMed ID: 1309678
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.